BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37293497)

  • 1. Age-related modifications in CYP-dependent drug metabolism: role of stress.
    Konstandi M; Johnson EO
    Front Endocrinol (Lausanne); 2023; 14():1143835. PubMed ID: 37293497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
    den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
    Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly.
    Wauthier V; Verbeeck RK; Calderon PB
    Curr Med Chem; 2007; 14(7):745-57. PubMed ID: 17346160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro.
    Chen D; Lin XX; Zhao Q; Xiao J; Peng SF; Xiao MF; Ouyang DS; Tan ZR; Wang YC; Peng JB; Zhang W; Chen Y
    Xenobiotica; 2017 Sep; 47(9):778-784. PubMed ID: 27571049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
    Xuan J; Chen S; Ning B; Tolleson WH; Guo L
    Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
    Hakkola J; Pelkonen O; Pasanen M; Raunio H
    Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism.
    Konstandi M; Johnson EO; Lang MA
    Neurosci Biobehav Rev; 2014 Sep; 45():149-67. PubMed ID: 24877684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
    Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
    Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.
    Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
    Zhou J; Wen Q; Li SF; Zhang YF; Gao N; Tian X; Fang Y; Gao J; Cui MZ; He XP; Jia LJ; Jin H; Qiao HL
    Oncotarget; 2016 Aug; 7(31):50612-50623. PubMed ID: 27203676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
    Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
    Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.
    Gao N; Tian X; Fang Y; Zhou J; Zhang H; Wen Q; Jia L; Gao J; Sun B; Wei J; Zhang Y; Cui M; Qiao H
    Eur J Pharm Sci; 2016 Sep; 92():86-97. PubMed ID: 27339126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Tomalik-Scharte D; Maiter D; Kirchheiner J; Ivison HE; Fuhr U; Arlt W
    Eur J Endocrinol; 2010 Dec; 163(6):919-24. PubMed ID: 20844025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypoxia and constitutionally different resistance to hypoxia/stress as the determiners of individual profile of cytochrome P450 isozyme activity.
    Bayanov AA; Brunt AR
    Gen Pharmacol; 1999 Oct; 33(4):355-61. PubMed ID: 10523075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
    Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
    Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450-mediated metabolism of estrogens and its regulation in human.
    Tsuchiya Y; Nakajima M; Yokoi T
    Cancer Lett; 2005 Sep; 227(2):115-24. PubMed ID: 16112414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.